{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:07:16Z","timestamp":1783897636429,"version":"3.55.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      Fibroblast activation protein (FAP), which is abundantly expressed in cancer-associated fibroblasts, is an attractive target for tumour imaging and therapy. [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-FAPI-46, a gallium-68-labelled FAP inhibitor, has demonstrated favourable pharmacokinetics for PET. This study evaluated the radiolabelling efficiency, stability, and biodistribution of [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-FAPI-46 in a breast cancer mouse model using MCF-7 cell line, which is known to lack FAP expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-FAPI-46 was radiolabeled directly from FAPI-46 using\n                      <jats:sup>68<\/jats:sup>\n                      Ga in acetate buffer and analysed for radiochemical purity (RCP) by radio-TLC. Stability at room temperature was assessed up to 5\u2005h post-radiolabeling. Biodistribution studies were conducted in female BALB\/c nude mice with MCF-7 tumours. Organ uptake was determined 1\u2009h after injection and expressed as a percentage of injected dose per gramme of tissue (%ID\/g). A comparative study between [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-FAPI-46 and free\n                      <jats:sup>68<\/jats:sup>\n                      Ga was also performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-FAPI-46 consistently achieved high RCP values (&gt;95%, maximum 99.1%) and remained stable for up to 5\u2005h without added radioprotectant. At 1\u2005h, [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-FAPI-46 showed higher uptake in kidneys (4.15%ID\/g), heart (3.59%ID\/g), and liver (1.70%ID\/g), and low uptake in muscle (0.31%ID\/g) and bone (0.57%ID\/g). Mean tumour uptake was low (0.92%ID\/g), consistent with the FAP-negative status of MCF-7 cells. In contrast, free\n                      <jats:sup>68<\/jats:sup>\n                      Ga showed a non-specific distribution in blood (29.13%ID\/g), lungs (18.50%ID\/g), and bone (13.37%ID\/g).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-FAPI-46 showed efficient radiolabelling with high RCP and short-term stability. Its low accumulation in FAP-negative tumours supports tracer selectivity and provides a baseline for comparative studies in FAP-expressing tumour models.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mnm.0000000000002131","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:00:13Z","timestamp":1772100013000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Preliminary in-vivo evaluation of [68Ga]Ga-FAPI-46 in a fibroblast activation protein\u2013negative breast cancer model"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5167-8063","authenticated-orcid":false,"given":"Hishar","family":"Hassan","sequence":"first","affiliation":[{"name":"Centre for Diagnostic Nuclear Imaging, Universiti Putra Malaysia, Serdang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Nadhira","family":"Jafperi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, Universiti Teknologi MARA, Bandar Puncak Alam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Hamirul Bahrin","family":"Wan Kamal","sequence":"additional","affiliation":[{"name":"Medical Technology Division, Malaysian Nuclear Agency (Nuclear Malaysia), Kajang, Selangor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifullizan","family":"Mohamad","sequence":"additional","affiliation":[{"name":"Medical Technology Division, Malaysian Nuclear Agency (Nuclear Malaysia), Kajang, Selangor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anee Suryani","family":"Sued","sequence":"additional","affiliation":[{"name":"Medical Technology Division, Malaysian Nuclear Agency (Nuclear Malaysia), Kajang, Selangor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Aminah","family":"Muhamad","sequence":"additional","affiliation":[{"name":"Medical Technology Division, Malaysian Nuclear Agency (Nuclear Malaysia), Kajang, Selangor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Faiz","family":"Mustaffa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, Universiti Teknologi MARA, Bandar Puncak Alam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazreen","family":"Waeleh","sequence":"additional","affiliation":[{"name":"Faculty of Electronics and Computer Technology and Engineering, Universiti Teknikal Malaysia Melaka, Durian Tunggal, Melaka, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairil Rashmizal","family":"Abdul Razak","sequence":"additional","affiliation":[{"name":"Medical Imaging Program, Department of Health and Care Professions, Faculty of Health and Life Sciences, St. Luke\u2019s Campus, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamad Faiz","family":"Othman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, Universiti Teknologi MARA, Bandar Puncak Alam"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"R1-20260712","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","article-title":"Updating the definition of cancer.","volume":"21","author":"Brown","year":"2023","journal-title":"Mol Cancer Res"},{"key":"R2-20260712","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets.","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol Cancer"},{"key":"R3-20260712","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","article-title":"Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives.","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R4-20260712","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/cancers15061899","article-title":"Cancer-associated fibroblasts: master tumor microenvironment modifiers.","volume":"15","author":"Wright","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R5-20260712","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy.","volume":"55","author":"Yang","year":"2023","journal-title":"Exp Mol Med"},{"key":"R6-20260712","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jare.2024.05.031","article-title":"Unlocking the crucial role of cancer-associated fibroblasts in tumor metastasis: mechanisms and therapeutic prospects.","volume":"71","author":"Liu","year":"2024","journal-title":"J Adv Res"},{"key":"R7-20260712","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts.","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol Rev"},{"key":"R8-20260712","first-page":"32","article-title":"Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer.","volume":"7","author":"Tokhanbigli","year":"2024","journal-title":"Cancer Drug Resist"},{"key":"R9-20260712","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/j.semnuclmed.2024.05.010","article-title":"Radiomolecular theranostics with fibroblast-activation-protein inhibitors and peptides.","volume":"54","author":"Baum","year":"2024","journal-title":"Semin Nucl Med"},{"key":"R10-20260712","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","article-title":"68Ga-FAPI-PET\/CT in patients with various gynecological malignancies.","volume":"48","author":"Dendl","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R11-20260712","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12929-024-01099-2","article-title":"Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects.","volume":"32","author":"Cao","year":"2025","journal-title":"J Biomed Sci"},{"key":"R12-20260712","doi-asserted-by":"crossref","first-page":"648187","DOI":"10.3389\/fonc.2021.648187","article-title":"Fibroblast activation protein-\u03b1 as a target in the bench-to-bedside diagnosis and treatment of tumors: a narrative review.","volume":"11","author":"Xin","year":"2021","journal-title":"Front Oncol"},{"key":"R13-20260712","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3390\/cancers15041193","article-title":"The superiority of fibroblast activation protein inhibitor (FAPI) PET\/CT versus FDG PET\/CT in the diagnosis of various malignancies.","volume":"15","author":"Dong","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R14-20260712","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/RLU.0000000000003489","article-title":"Fibroblast activation protein inhibitor PET\/CT: a promising molecular imaging tool.","volume":"46","author":"Sharma","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R15-20260712","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.3390\/cancers14163906","article-title":"Cancer-associated fibroblasts: tumorigenicity and targeting for cancer therapy.","volume":"14","author":"Glabman","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R16-20260712","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.chempr.2022.10.006","article-title":"Selective tumor targeting enabled by picomolar fibroblast activation protein inhibitors isolated from a DNA-encoded affinity maturation library.","volume":"9","author":"Puglioli","year":"2023","journal-title":"Chem"},{"key":"R17-20260712","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2121-15-16","article-title":"FAP-\u03b1 (Fibroblast activation protein-\u03b1) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway.","volume":"15","author":"Jia","year":"2014","journal-title":"BMC Cell Biol"},{"key":"R18-20260712","first-page":"194","article-title":"Tumor growth progression in ectopic and orthotopic xenografts from inflammatory breast cancer cell lines.","volume":"8","author":"Caceres","year":"2021","journal-title":"Vet Sci"},{"key":"R19-20260712","doi-asserted-by":"crossref","first-page":"8","DOI":"10.9734\/jammr\/2020\/v32i1730636","article-title":"Comparing the effect of methods of rat euthanasia on the brain of Wistar rats: cervical dislocation, chloroform inhalation, diethyl ether inhalation and formalin inhalation.","volume":"32","author":"Aguwa","year":"2020","journal-title":"J Adv Med Med Res"},{"key":"R20-20260712","doi-asserted-by":"crossref","first-page":"105518","DOI":"10.1016\/j.arabjc.2023.105518","article-title":"Development of novel radiolabeled antibody-conjugated graphene quantum dots for targeted in vivo breast cancer imaging and biodistribution studies.","volume":"17","author":"Ganji Arjenaki","year":"2024","journal-title":"Arabian J Chem"},{"key":"R21-20260712","doi-asserted-by":"crossref","first-page":"778396","DOI":"10.3389\/fphar.2021.778396","article-title":"Biodistribution study of niosomes in tumor-implanted BALB\/C mice using scintigraphic imaging.","volume":"12","author":"De Silva","year":"2022","journal-title":"Front Pharmacol"},{"key":"R22-20260712","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.apsb.2021.09.032","article-title":"Preclinical evaluation and pilot clinical study of [18F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts.","volume":"12","author":"Hu","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"R23-20260712","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s41181-022-00172-1","article-title":"Automated synthesis of [68Ga]Ga-FAPI-46 without pre-purification of the generator eluate on three common synthesis modules and two generator types.","volume":"7","author":"Alfteimi","year":"2022","journal-title":"EJNMMI Radiopharm Chem"},{"key":"R24-20260712","doi-asserted-by":"crossref","first-page":"108974","DOI":"10.1016\/j.nucmedbio.2024.108974","article-title":"Optimization and scale-up of [68Ga]Ga-FAPI-46 production on a Modular-Lab PharmTracer platform for clinical application.","volume":"140-141","author":"Brusa","year":"2025","journal-title":"Nucl Med Biol"},{"key":"R25-20260712","first-page":"2024","article-title":"An automated radiosynthesis of [68Ga]Ga-FAPI-46 for routine clinical use.","volume":"207","author":"Morandeau","year":"2024","journal-title":"J Vis Exp"},{"issue":"supplement 1","key":"R26-20260712","article-title":"<strong>Fully automated GMP production of [68Ga]Ga-FAPI-46 for clinical application in Taiwan<\/strong&gt.","volume":"64","author":"Li","year":"2023","journal-title":"J Nucl Med"},{"key":"R27-20260712","doi-asserted-by":"crossref","first-page":"1411312","DOI":"10.3389\/fchem.2024.1411312","article-title":"Development of a versatile [68Ga]Ga-FAPI-46 automated synthesis suitable to multi-elutions of germanium-68\/gallium-68 generators.","volume":"12","author":"Paty","year":"2024","journal-title":"Front Chem"},{"key":"R28-20260712","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/bc034109i","article-title":"Ascorbic acid: useful as a buffer agent and radiolytic stabilizer for metalloradiopharmaceuticals.","volume":"14","author":"Liu","year":"2003","journal-title":"Bioconjug Chem"},{"key":"R29-20260712","first-page":"101533","article-title":"In vivo biodistribution analysis of [68Ga]Ga-NOTA-pamidronic acid and [68Ga]Ga-DOTA-pamidronic acid: Insights into bone-targeting radiopharmaceuticals.","volume":"18","author":"Hassan","year":"2025","journal-title":"J Radiat Res Appl Sci"},{"key":"R30-20260712","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting cancer-associated fibroblasts.","volume":"59","author":"Loktev","year":"2018","journal-title":"J Nucl Med"},{"key":"R31-20260712","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.nucmedbio.2012.04.007","article-title":"68Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter.","volume":"39","author":"Fellner","year":"2012","journal-title":"Nucl Med Biol"},{"key":"R32-20260712","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"(68)Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers.","volume":"60","author":"Giesel","year":"2019","journal-title":"J Nucl Med"},{"key":"R33-20260712","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s41181-021-00144-x","article-title":"(18)F-labeled tracers targeting fibroblast activation protein.","volume":"6","author":"Lindner","year":"2021","journal-title":"EJNMMI Radiopharm Chem"},{"key":"R34-20260712","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1007\/s00259-022-05842-5","article-title":"Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy.","volume":"49","author":"Zboralski","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R35-20260712","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13550-024-01139-w","article-title":"Preclinical evaluation and first-in-human study of [(18)F]AlF-FAP-NUR for PET imaging cancer-associated fibroblasts.","volume":"14","author":"Liu","year":"2024","journal-title":"EJNMMI Res"},{"issue":"supplement 2","key":"R36-20260712","first-page":"241793","article-title":"Preclinical and pilot clinical evaluation of Al18F-FAP-NUR for PET imaging cancer-associated fibroblasts validated by immunohistochemistry, and clinical comparison with 18F-FDG.","volume":"65","author":"Zhang","year":"2024","journal-title":"J Nucl Med"},{"key":"R37-20260712","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1021\/acs.jmedchem.0c02171","article-title":"Imaging of fibroblast activation protein in cancer xenografts using novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules.","volume":"64","author":"Slania","year":"2021","journal-title":"J Med Chem"},{"key":"R38-20260712","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.2967\/jnumed.120.242958","article-title":"Targeting fibroblast activation protein: radiosynthesis and preclinical evaluation of an 18F-labeled FAP inhibitor.","volume":"61","author":"Toms","year":"2020","journal-title":"J Nucl Med"},{"key":"R39-20260712","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.humpath.2013.06.016","article-title":"Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer.","volume":"44","author":"Tchou","year":"2013","journal-title":"Hum Pathol"},{"key":"R40-20260712","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2021.04.016","article-title":"68Ga-FAPI-PET\/CT improves diagnostic staging and radiotherapy planning of adenoid cystic carcinomas \u2013 Imaging analysis and histological validation.","volume":"160","author":"R\u00f6hrich","year":"2021","journal-title":"Radiother Oncol"},{"key":"R41-20260712","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2967\/jnumed.120.253062","article-title":"Impact of 68Ga-FAPI PET\/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas.","volume":"62","author":"R\u00f6hrich","year":"2021","journal-title":"J Nucl Med"},{"key":"R42-20260712","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"(68)Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer.","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"R43-20260712","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.3390\/cancers13225744","article-title":"Radioligands targeting fibroblast activation protein (FAP).","volume":"13","author":"Lindner","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R44-20260712","doi-asserted-by":"crossref","first-page":"17848","DOI":"10.1038\/s41598-023-43049-2","article-title":"Comparison of early and late 68Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas.","volume":"13","author":"Hoppner","year":"2023","journal-title":"Sci Rep"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000002131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T22:50:29Z","timestamp":1783896629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000002131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":44,"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000002131","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"value":"0143-3636","type":"print"},{"value":"1473-5628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"2026-01-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}